Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori infection and prevention in high-altitude populations
ChiCTR2200063379Phase 4Not yet recruiting
- Sponsor
- 945th Hospital of the PLA Joint Logistic Support Force
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tigorazan in Helicobacter pylori infection (2 arms), sponsored by 945th Hospital of the PLA Joint Logistic Support Force. Primary endpoint: 13C-urea breath test negativity rate after treatment. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
tigorazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200063379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063379.